Drug Trial Radar · NCT01906879
Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection
Last checked: Nov 19, 2026Latest source record: Jun 12, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,620
Planned (sponsor's estimate)
Start
Jun 2013
Primary completion
Dec 2017
Study completion Dec 2017
Sponsor
- Lead sponsor
- National Taiwan University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 24, 2013
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Whether non-bismuth quadruple therapy (concomitant therapy) is more effective than bismuth quadruple therapy or triple therapy for 14 days remains unknown. Therefore, we aim to compare the eradication rates and long term re-infection rates of quadruple therapy for 10 days versus non-bismuth quadruple therapy for 10 days vs. triple therapy for 14 days. Methods: This will be a multi-center, open labeled, randomized control trial Patients: H. pylori infected patients who have willingness to receive eradication therapy Testing for H. pylori infection Before First Line Ttreatment (1)Any two positive of rapid urease test, histology, serology and culture or a positive UBT will be considered as H. pylori infected After First Line Treatment: C13-Urea breath test will be used to assess the existence of H. pylori 6-8 weeks after first line therapy. Long term reinfection: C13- Urea breath test will be used to assess the recurrence of H. pylori 1 year after eradication therapy
Conditions
- Helicobacter Pylori Infection
Interventions
triple, quadruple, non-bismuth quadruple therapyDrug
triple therapy, quadruple therapy, non-bismuth quadruple therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Eradication rate for H. pyloriTime frame: 6 weeks
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Chiayi Christian Hospital
Chiayi City, Taiwan · Recruiting
National Taiwan University Hospital, Hsinchu Branch
Hsinchu, Taiwan · Recruiting
E- DA Hospital and I-Shou University
Kaohsiung City, Taiwan · Recruiting
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan · Recruiting
Ming-Shiang Wu
Taipei, Taiwan · Recruiting
Mackay Memorial Hospital, Taipei
Taipei, Taiwan · Recruiting
Taipei Medical University Hospital
Taipei, Taiwan · Recruiting
Taipei Veterans General Hospital
Taipei, Taiwan · Recruiting
Mackay Memorial Hospital, Taitung
Taitung, Taiwan · Recruiting
National Taiwan University Hospital, Yun-Lin Branch
Yun-Lin County, Taiwan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.